Immunology

#Immunology #In vivo #Mouse models #T-Cells

Read the Top Five Benefits of a Cloud ELN

As experimental data becomes bigger and more complex, scientists are challenged to make discoveries faster, consistently document and analyse their work, and easily collaborate across an organisation and with external partners. Electronic lab notebooks (ELN) provide access to all collaborators 24/7, wherever they are and whether they are employees or… Read More

#Intelligence #Resources

Lab mouse
#Immunology #Mouse models #T-Cells

Whitepaper: The benefits of a mouse platform humanised with PBMCs

Mouse models with human immune cell engraftment provide platforms to evaluate compounds to treat a variety of human diseases. Humanised PBMC (hu-PBMC) mice feature quick engraftment of adult peripheral blood mononuclear cells and enable short-term studies requiring mature human T cells. Hu-PBMC mice are used as in vivo models to… Read More

#News

#Immunology #In vivo #Mouse models #T-Cells

The latest MHC class I & II deficient in vivo platform humanised with PBMCs

This whitepaper, brought to you by The Jackson Laboratory will teach: The benefits of the JAX NSGTM-MHC I/II KO mouse platform humanised with pre-characterised PBMCs How this platform can support a wide range of immunological studies, especially those containing T cells responses The versatility of this platform to various research disciplines… Read More

#Intelligence #Resources

Professor Melief
#Cancer #Cancer research #Immunology #Immunotherapy #Oncology

ISA Pharmaceuticals’ founder recognised by SITC

Professor Dr Cornelis (‘Kees’) Melief has been awarded the 2022 Pedro J Romero Service to JITC Award by the Society for Immunotherapy of Cancer (SITC).  The Award recognises individuals who have made immeasurable contributions and demonstrated outstanding commitment to the Journal for Immunotherapy of Cancer (JITC) and will be… Read More

#News

#Covid-19 #Immunology #Immunology / Virology & Vaccines

Promising developments in pursuit to design pan-coronavirus vaccine

Researchers at the Francis Crick Institute in the UK, have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics. Developing a vaccine that provides… Read More

#Editor's Choice #News #Trending News

#Collaboration #Immunology #Oncology

Amphista Therapeutics signs on drug development projects  

Amphista Therapeutics, a company focused on the development of next generation targeted protein degradation (TPD) therapeutics, has signed a strategic collaboration and license agreement with Bristol Myers Squibb.   The companies will work together to discover and develop small molecule protein degraders. Bristol Myers Squibb will be granted a global… Read More

#News

#Autoimmune disease #Immunology #Pharma

Understanding and innovating in immunology

Listen to this article on the DDW Podcast: Chiedzo Mpofu, Vice President, Global Medical Affairs Head, Immunology, at AbbVie, talks to Lu Rahman about our understanding of auto-immune disease and how AbbVie is continuing to innovate in this field. "Immune mediated diseases are a diverse group of conditions that share common… Read More

#Exclusive Content

#Cell and gene therapy #Immunology #SLAS Europe

The spring issue of Drug Discovery World magazine is out now 

Featuring Specialty Spotlight on Immunology, the magazine is available to download and read for free on the DDW App.    Key features of the spring issue include:  Can age-related disease be a thing of the past? Cell & Gene Therapies: Opportunities… Read More

#News

#App note #Drug targets #Immunology

Targeting kinases involved in the innate immune response: App note

A new app note, brought to you by BellBrook Labs and supported by DDW, is available to download for free here.  Clinical trials continue to determine whether therapeutic modulation of kinases can be used to suppress the immune system in autoimmune diseases or stimulate for… Read More

#News

#Collaboration #Immunology

Scientists uncover unique immune cell surveillance mechanism 

Researchers at the Francis Crick Institute and King’s College London have identified how specialist immune cells, called gamma delta T cells (γδ T cells), sense the body’s status quo, enabling them to assess the health of surface tissues and even protect against cancer-causing DNA damage.  Context … Read More

#News

#AI / data analytics / healthtech / informatics #AstraZeneca #Drug targets #Immunology

AstraZeneca uses AI platform to target idiopathic pulmonary fibrosis 

AstraZeneca has added a novel target for idiopathic pulmonary fibrosis (IPF) to its drug development portfolio, discovered using BenevolentAI’s platform. This is reportedly the second novel target from the collaboration that has been identified, validated, and selected for AstraZeneca’s portfolio.   The collaboration  BenevolentAI’s collaboration with AstraZeneca currently focuses… Read More

#News #Trending News

#Antibodies #Immune cells #Immunology

Scientists reveal how the body controls allergy-causing immune cells 

Scientists at the Francis Crick Institute have uncovered biological processes key to regulating immune cells that can cause allergic reactions unless closely controlled, which they hope could help expose what goes wrong when the body develops allergies or goes into anaphylaxis.  Background  IgE antibodies are… Read More

#News

#Biomedical research #Biotechnology #Immunology

Spatial biology imaging platform dedicated to skin

Genoskin, a biotechnology company using live ex vivo human skin to test therapeutic and non-therapeutic products, has launched Mantis, a new spatial biology imaging platform dedicated to skin immunology. This new offer was developed by Genoskin’s recently appointed CSO Dr. Nicolas Gaudenzio and his team at Inserm.   What is Mantis?  … Read More

#News

#Cell therapy #Drug development #Drug discovery #Immunology

Bone marrow backup needed to tackle respiratory infections 

Scientists at the Francis Crick Institute have found how the immune system triggers an ‘emergency’ dendritic cell response during infection, with dendritic cells at the site of infection being reinforced by new cells which travel from the bone marrow.   Dendritic cells have an important role in the… Read More

#News #Trending News